Home/Filings/4/0001144204-18-062649
4//SEC Filing

TAUB MALCOLM S 4

Accession 0001144204-18-062649

CIK 0001137883other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 5:01 PM ET

Size

5.4 KB

Accession

0001144204-18-062649

Insider Transaction Report

Form 4
Period: 2018-11-30
Transactions
  • Award

    Common Stock

    2018-11-30+12,00041,332 total
Footnotes (1)
  • [F1]Shares acquired are shares of restricted stock awarded on November 30, 2018 pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on December 30, 2018 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1
  • filerCIK 0001305117

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 5:01 PM ET
Size
5.4 KB